NKAIN1P2

Across TCGA pan-cancer cohorts, NKAIN1P2 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated NKAIN1P2 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher NKAIN1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NKAIN1P2 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

PAAD, UCS, and BLCA are the cancer types where NKAIN1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.094	0.640	<.001	72	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
BLCA	OS	Tertile	IV	0.267	0.597	.007	36	view →
THCA	OS	Tertile	III,IV	0.240	0.795	.006	18	view →
ACC	DFS	Tertile	All	0.089	0.622	.030	9	view →
KIRC	DFS	Tertile	III,IV	0.884	0.624	.048	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

NKAIN1P2–PAAD (OS)

Open the PAAD breakdown →